Evidence map›Paper›PMID 39406474›Full record

ArticleClinical and translational medicine2024

Prognosis-oriented molecular subtypes of retroperitoneal liposarcoma.

Mengmeng Xiao, Da Qin, Xiangji Li, Fanqin Bu, Shixiang Ma, Xiaobing Chen, Yu Zhao, Chenghua Luo, Li Min

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and translational medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mengmeng Xiao *Department of General Surgery, Peking University People's Hospital, Beijing, P. R. China.
Da Qin *Department of Gastroenterology, State Key Laboratory for Digestive Health, National Clinical Research Center for Digestive Disease, Beijing Digestive Disease Center, Beijing Key Laboratory for Precancerous Lesion of Digestive Disease, Beijing Friendship Hospital, Capital Medical University, Beijing, P. R. China.
Xiangji Li *Department of Gastroenterology, State Key Laboratory for Digestive Health, National Clinical Research Center for Digestive Disease, Beijing Digestive Disease Center, Beijing Key Laboratory for Precancerous Lesion of Digestive Disease, Beijing Friendship Hospital, Capital Medical University, Beijing, P. R. China.
Fanqin BuDepartment of Gastroenterology, State Key Laboratory for Digestive Health, National Clinical Research Center for Digestive Disease, Beijing Digestive Disease Center, Beijing Key Laboratory for Precancerous Lesion of Digestive Disease, Beijing Friendship Hospital, Capital Medical University, Beijing, P. R. China.
Shixiang MaDepartment of Retroperitoneal Tumor Surgery, Peking University International Hospital, Beijing, P. R. China.
Xiaobing ChenDepartment of Retroperitoneal Tumor Surgery, Peking University International Hospital, Beijing, P. R. China.
Yu ZhaoDepartment of Gastroenterology, State Key Laboratory for Digestive Health, National Clinical Research Center for Digestive Disease, Beijing Digestive Disease Center, Beijing Key Laboratory for Precancerous Lesion of Digestive Disease, Beijing Friendship Hospital, Capital Medical University, Beijing, P. R. China.
Chenghua LuoDepartment of General Surgery, Peking University People's Hospital, Beijing, P. R. China.ORCID 0000-0002-5939-7888
Li MinDepartment of Gastroenterology, State Key Laboratory for Digestive Health, National Clinical Research Center for Digestive Disease, Beijing Digestive Disease Center, Beijing Key Laboratory for Precancerous Lesion of Digestive Disease, Beijing Friendship Hospital, Capital Medical University, Beijing, P. R. China.ORCID 0000-0001-9595-5536

Funding

National Natural Science Foundation of China 82073390Young Elite Scientists Sponsorship Program 2023QNRC001
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

LiposarcomaRetroperitoneal NeoplasmsAgedFemaleHumansMaleMiddle AgedPrognosis

Identifiers

PMID39406474
PMCPMC11479751

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.